Literature DB >> 29701279

Reuse of data sources to evaluate drug safety signals: When is it appropriate?

Shirley V Wang1, Martin Kulldorff1, Robert J Glynn1, Joshua J Gagne1, Anton Pottegård2, Kenneth J Rothman3, Sebastian Schneeweiss1, Alexander M Walker4.   

Abstract

Mesh：

Year:  2018        PMID： 29701279     DOI： 10.1002/pds.4442

Source DB:  PubMed          Journal:  Pharmacoepidemiol Drug Saf        ISSN： 1053-8569            Impact factor:   2.890


× No keyword cloud information.
  6 in total

1.  Identifying signals of interest when screening for drug-outcome associations in health care data.

Authors:  Anton Pottegård; Jesper Hallas; Shirley V Wang; Joshua J Gagne
Journal:  Br J Clin Pharmacol       Date:  2018-06-03       Impact factor: 4.335

2.  Hypothesis-free signal detection in healthcare databases: finding its value for pharmacovigilance.

Authors:  Andrew Bate; Ken Hornbuckle; Juhaeri Juhaeri; Stephen P Motsko; Robert F Reynolds
Journal:  Ther Adv Drug Saf       Date:  2019-08-05

3.  A systematic assessment of the association between frequently prescribed medicines and the risk of common cancers: a series of nested case-control studies.

Authors:  R D McDowell; C Hughes; P Murchie; C Cardwell
Journal:  BMC Med       Date:  2021-01-26       Impact factor: 8.775

4.  Intra-database validation of case-identifying algorithms using reconstituted electronic health records from healthcare claims data.

Authors:  Nicolas H Thurin; Pauline Bosco-Levy; Patrick Blin; Magali Rouyer; Jérémy Jové; Stéphanie Lamarque; Séverine Lignot; Régis Lassalle; Abdelilah Abouelfath; Emmanuelle Bignon; Pauline Diez; Marine Gross-Goupil; Michel Soulié; Mathieu Roumiguié; Sylvestre Le Moulec; Marc Debouverie; Bruno Brochet; Francis Guillemin; Céline Louapre; Elisabeth Maillart; Olivier Heinzlef; Nicholas Moore; Cécile Droz-Perroteau
Journal:  BMC Med Res Methodol       Date:  2021-05-01       Impact factor: 4.615

5.  Investigation of the potential association between the use of fluoxetine and occurrence of acute pancreatitis: a Danish register-based cohort study.

Authors:  Mia Aakjær; Sarah Brøgger Kristiansen; Kathrine Pape; Maurizio Sessa; Kim Peder Dalhoff; Marie Louise De Bruin; Morten Andersen
Journal:  Int J Epidemiol       Date:  2022-10-13       Impact factor: 9.685

6.  Inferences About Drug Safety in Phase III Trials in Oncology: Examples From Advanced Prostate Cancer.

Authors:  Joshua Z Drago; Mithat Gönen; Gita Thanarajasingam; Chana A Sacks; Michael J Morris; Philip W Kantoff; Konrad H Stopsack
Journal:  J Natl Cancer Inst       Date:  2021-05-04       Impact factor: 13.506
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.